{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:08:03Z","timestamp":1783487283361,"version":"3.55.0"},"reference-count":48,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,5,15]]},"abstract":"<jats:p>GPCRs (G-protein-coupled receptors) exist in a spontaneous equilibrium between active and inactive conformations that are stabilized by agonists and inverse agonists respectively. Because ligand binding of agonists and inverse agonists often occurs in a competitive manner, one can assume an overlap between both binding sites. Only a few studies report mutations in GPCRs that convert receptor blockers into agonists by unknown mechanisms. Taking advantage of a genetically modified yeast strain, we screened libraries of mutant M3Rs {M3 mAChRs [muscarinic ACh (acetylcholine) receptors)]} and identified 13 mutants which could be activated by atropine (EC50 0.3\u201310\u00a0\u03bcM), an inverse agonist on wild-type M3R. Many of the mutations sensitizing M3R to atropine activation were located at the junction of intracellular loop 3 and helix 6, a region known to be involved in G-protein coupling. In addition to atropine, the pharmacological switch was found for other M3R blockers such as scopolamine, pirenzepine and oxybutynine. However, atropine functions as an agonist on the mutant M3R only when expressed in yeast, but not in mammalian COS-7 cells, although high-affinity ligand binding was comparable in both expression systems. Interestingly, we found that atropine still blocks carbachol-induced activation of the M3R mutants in the yeast expression system by binding at the high-affinity-binding site (Ki \u223c10\u00a0nM). Our results indicate that blocker-to-agonist converting mutations enable atropine to function as both agonist and antagonist by interaction with two functionally distinct binding sites.<\/jats:p>","DOI":"10.1042\/bj20071366","type":"journal-article","created":{"date-parts":[[2008,4,25]],"date-time":"2008-04-25T13:56:03Z","timestamp":1209131763000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Generation of an agonistic binding site for blockers of the M3 muscarinic acetylcholine receptor"],"prefix":"10.1042","volume":"412","author":[{"given":"Doreen","family":"Thor","sequence":"first","affiliation":[{"name":"Institute of Biochemistry, Molecular Biochemistry, Medical Faculty, University of Leipzig, Johannisallee 30, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Schulz","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, Molecular Biochemistry, Medical Faculty, University of Leipzig, Johannisallee 30, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hermsdorf","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, Molecular Biochemistry, Medical Faculty, University of Leipzig, Johannisallee 30, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Sch\u00f6neberg","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, Molecular Biochemistry, Medical Faculty, University of Leipzig, Johannisallee 30, 04103 Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2008,4,25]]},"reference":[{"key":"2021112214591112300_B1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0024-3205(95)00028-5","article-title":"Muscarinic acetylcholine receptors: structural basis of ligand binding and G protein coupling","volume":"56","author":"Wess","year":"1995","journal-title":"Life Sci."},{"key":"2021112214591112300_B2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.lfs.2004.10.029","article-title":"The pharmacological action of MT-7","volume":"76","author":"Onali","year":"2005","journal-title":"Life Sci."},{"key":"2021112214591112300_B3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2004.05.002","article-title":"Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function","volume":"103","author":"Kristiansen","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"2021112214591112300_B4","doi-asserted-by":"crossref","first-page":"24433","DOI":"10.1074\/jbc.C100162200","article-title":"Functionally different agonists induce distinct conformations in the G protein coupling domain of the \u03b22 adrenergic receptor","volume":"276","author":"Ghanouni","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B5","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1073\/pnas.101126198","article-title":"Agonist-induced conformational changes in the G-protein-coupling domain of the \u03b22 adrenergic receptor","volume":"98","author":"Ghanouni","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214591112300_B6","doi-asserted-by":"crossref","first-page":"15248","DOI":"10.1074\/jbc.M312728200","article-title":"\u201cNetwork leaning\u201d as a mechanism of insurmountable antagonism of the angiotensin II type\u00a01 receptor by non-peptide antagonists","volume":"279","author":"Takezako","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nchembio705","article-title":"Molecular basis of inverse agonism in a G protein-coupled receptor","volume":"1","author":"Vilardaga","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"2021112214591112300_B8","doi-asserted-by":"crossref","first-page":"26284","DOI":"10.1074\/jbc.M704875200","article-title":"Distinct structural changes in a G protein-coupled receptor caused by different classes of agonist ligands","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/pr.57.2.2","article-title":"Multiple signaling states of G-protein-coupled receptors","volume":"57","author":"Perez","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"2021112214591112300_B10","doi-asserted-by":"crossref","first-page":"22165","DOI":"10.1074\/jbc.M502352200","article-title":"Probing the \u03b22 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists","volume":"280","author":"Swaminath","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/protein\/gzi069","article-title":"Creation of GPCR-based chemical sensors by directed evolution in yeast","volume":"19","author":"Ault","year":"2006","journal-title":"Protein Eng. Des. Sel."},{"key":"2021112214591112300_B12","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1074\/jbc.M007748200","article-title":"An activation switch in the ligand binding pocket of the C5a receptor","volume":"276","author":"Gerber","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1124\/mol.54.5.857","article-title":"Mutations within the cholecystokinin-B\/gastrin receptor ligand \u2018pocket\u2019 interconvert the functions of nonpeptide agonists and antagonists","volume":"54","author":"Blaker","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"2021112214591112300_B14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1074\/jbc.C200588200","article-title":"A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL)","volume":"278","author":"Claeysen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1073\/pnas.95.1.352","article-title":"Controlling signaling with a specifically designed Gi-coupled receptor","volume":"95","author":"Coward","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214591112300_B16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0167-7799(97)01119-0","article-title":"G-protein-coupled receptors in Saccharomyces cerevisiae: high-throughput screening assays for drug discovery","volume":"15","author":"Pausch","year":"1997","journal-title":"Trends Biotechnol."},{"key":"2021112214591112300_B17","first-page":"105","article-title":"Intensive mutational analysis of G protein-coupled receptors in yeast","volume":"237","author":"Celic","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"2021112214591112300_B18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.tips.2005.08.005","article-title":"Techniques: how to boost GPCR mutagenesis studies using yeast","volume":"26","author":"Beukers","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"2021112214591112300_B19","doi-asserted-by":"crossref","first-page":"35393","DOI":"10.1074\/jbc.M005602200","article-title":"Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function","volume":"275","author":"Geva","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B20","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1074\/jbc.M411623200","article-title":"Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast: identification of second-site mutations that restore function to a coupling-deficient mutant M3 receptor","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B21","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1073\/pnas.0700293104","article-title":"Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand","volume":"104","author":"Armbruster","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112214591112300_B22","doi-asserted-by":"crossref","first-page":"18000","DOI":"10.1074\/jbc.270.30.18000","article-title":"Plasma membrane localization and functional rescue of truncated forms of a G protein-coupled receptor","volume":"270","author":"Sch\u00f6neberg","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B23","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1046\/j.1471-4159.1999.0722404.x","article-title":"Conserved extracellular cysteine pair in the M3 muscarinic acetylcholine receptor is essential for proper receptor cell surface localization but not for G protein coupling","volume":"72","author":"Zeng","year":"1999","journal-title":"J. Neurochem."},{"key":"2021112214591112300_B24","doi-asserted-by":"crossref","first-page":"31055","DOI":"10.1074\/jbc.271.49.31055","article-title":"Functional role of the third cytoplasmic loop in muscarinic receptor dimerization","volume":"271","author":"Maggio","year":"1996","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B25","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1046\/j.1471-4159.2001.00344.x","article-title":"Functional expression of M1, M3 and M5 muscarinic acetylcholine receptors in yeast","volume":"77","author":"Erlenbach","year":"2001","journal-title":"J. Neurochem."},{"key":"2021112214591112300_B26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/nar\/25.2.451","article-title":"Recombination-mediated PCR-directed plasmid construction in vivo in yeast","volume":"25","author":"Oldenburg","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"2021112214591112300_B27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1042\/bj2120849","article-title":"Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol","volume":"212","author":"Berridge","year":"1983","journal-title":"Biochem. J."},{"key":"2021112214591112300_B28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1124\/jpet.105.094383","article-title":"Constitutive activity and inverse agonism at the M2 muscarinic acetylcholine receptor","volume":"316","author":"Nelson","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021112214591112300_B29","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.M107647200","article-title":"Conformational changes that occur during M3 muscarinic acetylcholine receptor activation probed by the use of an in situ disulfide cross-linking strategy","volume":"277","author":"Ward","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B30","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/jpet.107.120519","article-title":"Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity","volume":"321","author":"Preuss","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021112214591112300_B31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.tips.2007.06.008","article-title":"Allosteric enhancers, allosteric agonists and agoallosteric modulators: where do they bind and how do they act?","volume":"28","author":"Schwartz","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"2021112214591112300_B32","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.tips.2007.06.011","article-title":"Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates","volume":"28","author":"Baker","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"2021112214591112300_B33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0024-3205(97)00041-6","article-title":"Structural basis of receptor\/G protein coupling selectivity studied with muscarinic receptors as model systems","volume":"60","author":"Wess","year":"1997","journal-title":"Life Sci."},{"key":"2021112214591112300_B34","doi-asserted-by":"crossref","first-page":"30248","DOI":"10.1074\/jbc.M304991200","article-title":"Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast. Identification of point mutations that \u201csilence\u201d a constitutively active mutant M3 receptor and greatly impair receptor\/G protein coupling","volume":"278","author":"Schmidt","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1124\/mol.51.2.312","article-title":"Pharmacology of muscarinic receptor subtypes constitutively activated by G proteins","volume":"51","author":"Burstein","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"2021112214591112300_B36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbrc.2004.09.034","article-title":"Functional expression of human and mouse P2Y12 receptors in Saccharomyces cerevisiae","volume":"324","author":"Pausch","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021112214591112300_B37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11302-005-6310-1","article-title":"Signaling of the human P2Y(1) receptor measured by a yeast growth assay with comparisons to assays of phospholipase C and calcium mobilization in 1321N1 human astrocytoma cells","volume":"1","author":"Niebauer","year":"2005","journal-title":"Purinergic Signal."},{"key":"2021112214591112300_B38","doi-asserted-by":"crossref","first-page":"21563","DOI":"10.1074\/jbc.273.34.21563","article-title":"Identification of a ligand-dependent switch within a muscarinic receptor","volume":"273","author":"Spalding","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/mol.58.1.175","article-title":"Scanning mutagenesis identifies amino acid side chains in transmembrane domain 5 of the M1 muscarinic receptor that participate in binding the acetyl methyl group of acetylcholine","volume":"58","author":"Allman","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"2021112214591112300_B40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nmeth990","article-title":"Rapid identification of functionally critical amino acids in a G protein-coupled receptor","volume":"4","author":"Li","year":"2007","journal-title":"Nat. Methods."},{"key":"2021112214591112300_B41","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1124\/mol.63.6.1312","article-title":"Agonist actions of \u201cbeta-blockers\u201d provide evidence for two agonist activation sites or conformations of the human \u03b21-adrenoceptor","volume":"63","author":"Baker","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"2021112214591112300_B42","doi-asserted-by":"crossref","first-page":"18120","DOI":"10.1074\/jbc.M601791200","article-title":"Novel mutants of the human \u03b21-adrenergic receptor reveal amino acids relevant for receptor activation","volume":"281","author":"Behr","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B43","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1021\/bi051503q","article-title":"Use of an in situ disulfide cross-linking strategy to study the dynamic properties of the cytoplasmic end of transmembrane domain VI of the M3 muscarinic acetylcholine receptor","volume":"45","author":"Ward","year":"2006","journal-title":"Biochemistry."},{"key":"2021112214591112300_B44","doi-asserted-by":"crossref","first-page":"12470","DOI":"10.1021\/bi960849l","article-title":"Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study","volume":"35","author":"Altenbach","year":"1996","journal-title":"Biochemistry."},{"key":"2021112214591112300_B45","doi-asserted-by":"crossref","first-page":"9279","DOI":"10.1074\/jbc.M004871200","article-title":"Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the \u03b22 adrenergic receptor mapped by site-selective fluorescent labeling","volume":"276","author":"Jensen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021112214591112300_B46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/mol.56.1.175","article-title":"Mutation of a highly conserved aspartic acid in the \u03b22 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6","volume":"56","author":"Rasmussen","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"2021112214591112300_B47","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0165-6147(00)01743-0","article-title":"Engineering receptors activated solely by synthetic ligands (RASSLs)","volume":"22","author":"Scearce-Levie","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"2021112214591112300_B48","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/412\/1\/103\/651626\/bj4120103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/412\/1\/103\/651626\/bj4120103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T19:44:04Z","timestamp":1637610244000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/412\/1\/103\/44305\/Generation-of-an-agonistic-binding-site-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,25]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5,15]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20071366","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,25]]}}}